!!! New Study Publication!!!
"Active Chest Tube Clearance Added to an Enhanced Recovery After Cardiac Surgery (ERAS) Program Improves Outcomes and Reduces Resource Utilization"


Adding PleuraFlow’s Active Chest Tube Clearance (ATC) to an ERAS cardiac surgery program reduced Retained Blood Syndrome by 41%, postoperative atrial fibrillation (POAF) by 17%, and ICU time by 30% in 684 patients compared to 650 controls, improving outcomes and resource utilization. (Gerdisch, et al, 2025)

Economic Benefits & Considerations

Cost

Retained Blood Syndrome Can Be Serious and Costly

Healthcare costs are seriously impacted by Retained Blood Syndrome (RBS). What’s worse, RBS patients suffer double the mortality rate and experience on average 5.8 days longer length of stay.15

 

Calculator

Calculate the Potential Financial Benefits for Your Hospital

Volume
Payor Mix
$
%
$
%
Average Diagnosis Related Groups Reimbursement
%
Impact of Retained Blood
%
$
$
$
Benefit of PleuraFlow
%
$
$
%
$
Financial Benefit of PleuraFlow Use
$
$
$
$

Citations

1 Dexur Medicare claims data analysis 2017-2020.

2 Average 90 day cost of care per hospitalization difference with and without Retained Blood.

3 Packed Red Blood Cells, Fresh Frozen Plasma, Cryoprecipitate, and Platelets

4 Arthur Zbrozek, Glenn Magee, Cost of Bleeding in Trauma and Complex Cardiac Surgery, Clinical Therapeutics, Volume 37, Issue 9, 2015, Pages 1966-1974, ISSN 0149-2918, https://doi.org/10.1016/j.clinthera.2015.06.007.

5 Sirch J, Ledwon M, Puski T, Boyle EM, Pfeiffer S, Fischlein T. Active Clearance of Chest Drainage Catheters Reduces Retained Blood. Journal of Thoracic and Cardiovascular Surgery. 2016. Mar; 151(3):832–838.

6 Baribeau, Y., Westbrook, B., et al. Active clearance of chest tubes is associated with reduced postoperative complications and costs after cardiac surgery: a propensity matched analysis. J Cardiothoracic Surg 14, 192 (2019) doi:10.1186/s13019-019-09.